• 1. Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
  • 2. West China Second University Hospital, Sichuan University/West China Women’s and Children’s Hospital, Chengdu, 610041, P.R.China;
  • 3. Sichuan Provincial Hospital for Women and Children, Chengdu, 610045, P.R.China;
  • 4. Panzhihua Central Hospital, Panzhihua, 617000, P.R.China;
  • 5. Chongqing Health Center for Women and Children, Chongqing, 400010, P.R.China;
  • 6. Women’s Hospital School of Medicine, Zhejiang University, Hangzhou, 310006, P.R.China;
  • 7. Xiamen Medical Center for Women and Children, Xiamen, 361003, P.R.China;
  • 8. Wenzhou People's Hospital, Wenzhou, 325000, P.R.China;
  • 9. Suzhou Second People's Hospital/ Suzhou Municipal Hospital, Suzhou, 215002, P.R.China;
  • 10. Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P.R.China;
  • 11. Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, P.R.China;
  • 12. The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, P.R.China;
  • 13. The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, P.R.China;
  • 14. Shanxi Provincial Hospital for Women and Children/ Northwest Women’s and Children’s Hospital, Xi'an, 710000, P.R.China;
  • 15. The Second Affiliated Hospital of Shanxi University of Traditional Chinese Medicine, Xianyang, 712000, P.R.China;
  • 16. Yan'an University Affiliated Hospital, Yan’an, 716000, P.R.China;
  • 17. Maternal and Child Health Hospital of Urumchi, Xinjiang, Urumchi, 830000, P.R.China;
  • 18. Shengjing Hospital of China Medical University, Shenyang, 110004, P.R.China;
  • 19. Maternal and Child Health Hospital of Dalian, Dalian, 116000, P.R.China;
  • 20. Changchun Obstetrics-Gynecology Hospital, Changchun, 130042, P.R.China;
  • 21. The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, P.R.China;
  • 22. Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 100006, P.R.China;
  • 23. Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, 300100, P.R.China;
  • 24. The Fourth Hospital of Shijiazhuang/Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, 050011, P.R.China;
  • 25. Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, P.R.China;
LIU Xinghui, Email: xinghuiliu@163.com
Export PDF Favorites Scan Get Citation

Objective To understand the distribution of demographic sociological characteristics and co-morbidities among primiparous and multiparous pregnant women under the China's universal two-child policy, to provide baseline data for clinical high-risk management and medical resources allocation.Methods We included pregnant women from 24 hospitals in 16 provinces (municipality, autonomous region) of China and collected their demographic sociological characteristics and obstetrics information by questionnaires between September 19th, and November 20th, 2016. Then, we used descriptive analysis to present the distribution of demographic sociological characteristics and pregnancy co-morbidities among primiparous and multiparous women and compared differences between groups by t test or Chi-square test.Results Among 12 403 investigated pregnant women, 8 268 (66.7%) were primiparous and 4 135 (33.3%) were multiparous, with highest proportion in East (931/2 008, 46.4%) and lowest in Northeast (385/2 179, 17.7%). Multiparous women, comparing to primiparous women, were more likely to be elderly than 35 years (accounting for 30.6% vs. 6.5%), lower educated with high school or below (29.7% vs. 16.9%), occupied in physical labor or unemployed (49.2% vs. 42.5%), non-local residents (12.7% vs. 10.5%), family annual income higher than 120 thousand yuan (41.3% vs. 33.3%), pre-pregnancy body mass index≥24 kg/m2 (13.6% vs. 9.9%), history of artificial abortions (44.9% vs. 24.0%), or pregnancies≥4 times (23.8% vs. 3.1%) and were less likely to receive assisted reproductive technology (2.3% vs. 4.7%). The most common co-morbidities were gynecology disease (5.5%), thyroid disease (5.4% in all women), blood system disease (5.0%), digestive system disease (4.2%) and hepatitis B infection (2.5%). Multiparous women, comparing to primiparous women, had higher proportions with blood system disease (5.7% vs. 4.7%), hepatitis B infection (3.1% vs. 2.2%) and chronic hypertension (0.6% vs. 0.2%), but lower proportions with thyroid diseases, polycystic ovary syndrome, and immune system diseases, whose distribution also showed regional differences.Conclusion There existed distribution differences regarding demographic sociological characteristics and co-morbidities proportions between primiparous and multiparous women. Therefore, we should improve clinical risk management and medical resources allocation based on pregnant women’s baseline and gestational characteristics.

Citation: QI Yana, TAN Jing, SUN Xin, HE Guolin, YANG Hongmei, LIU Xinghui, GAO Yan, LIU Xiuli, ZHOU Wei, HE Jing, CHEN Lu, ZHANG Xueqin, ZHANG Hongping, WANG Yun, XU Xiufen, ZOU Li, XIAO Mei, PENG Min, ZHAO Xianlan, ZHOU Yan, TANG Hui, CAO Yinli, YUAN Ningxia, LI Hongmei, DING Guifeng, PENG Yan, LIU Caixia, QIAO Chong, ZHAN Fang, YIN Chunxia, CAI Yan, FAN Ling, LI Jieyan, CHEN Xu, ZHANG Guohua, ZHANG Jiewen. Distribution of demographic sociological characteristics and co-morbidities among primiparous and multiparous pregnant women: a national cross-sectional study of 24 hospitals in 16 provinces. Chinese Journal of Evidence-Based Medicine, 2020, 20(2): 134-143. doi: 10.7507/1672-2531.201906042 Copy

  • Previous Article

    Disease control of 2019 novel coronavirus infection in hospital: West China urgent recommendation
  • Next Article

    Association of body mass index and mortality in chronic heart failure: a meta-analysis